, Volume 11, Issue 3, pp 99–102 | Cite as

19-Hydroxylation ofΔ4-androstene-3,17-dione and dehydroepiandrosterone by bovine adrenals

  • A. S. Meyer
Kurze Mitteilungen


Steroid Dion Dehydroepiandrosteron Bovine Adrenal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Die Aufklärung der Struktur von 19-Oxy-Δ4-androsten-3,17-dion (VI), einer Substanz, isoliert nach Inkubation von Δ4-Androsten-3,17-dion und von Dehydroepiandrosteron mit einem Rinder-Nebennieren-Homogenat, ist beschrieben. Dies ist unseres Wissens die erste Beobachtung der Hydroxylierungin vitro einer angulären Methylgruppe eines Steroids. Mehrere Folgerungen sind erörtert.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. S. Meyer, M. Hayano, M. C. Lindberg, M. Gut, andO. G. Rodgers, Acta Endocrin.18, 148 (1955).Google Scholar
  2. 1.
    A. S. Meyer, H. Rosenkrantz, andG. Pincus, Amer. Chem. Soc. 126th Meeting, Abstract p. 53–0, New York, 1954.Google Scholar
  3. 1a.
    The absence of an isolated olefinic bond in compound VI has been kindly confirmed by Dr.R. Norman Jones who examined the infrared absorption of the compound in chloroform solution with a Perkin-Elmer double-beam spectrophotometer with a sodium chloride prism (R. N. Jones, P. Humphries, E. Packard, andK. Dobriner, J. Amer. Chem. Soc.72, 86 [1950]), and was unable to detect any evidence of an unsaturation other than theΔ 4-bond.CrossRefGoogle Scholar
  4. 2.
    TheR-values indicate the mobilities of the substances in the ligroin- and toluene-propylene glycol paper chromatographic system respectively as defined previously (A. S. Meyer, M. Hayano, M. C. Lindberg, M. Gut, andO. G. Rodgers, Acta Endocrin. [l. c.]). For compound II for instance aR lig 2·2 cm/h and for compound IV aR tol 4·0 cm/b have been determined.Google Scholar
  5. 3.
    S. H. Eppstein, P. D. Meister, H. M. Leigh, D. H. Peterson, M. C. Murray, L. M. Reineke, andA. Weintraub, J. Amer. Chem. Soc.76, 3174 (1954).CrossRefGoogle Scholar
  6. 4.
    Ch. Meystre andA. Wettstein, Helv. chim. Acta32, 1978 (1949).CrossRefGoogle Scholar
  7. 5.
    Dr.Josef Fried, private communication.Google Scholar
  8. 1.
    G. I. Poos, G. E. Arth, R. E. Beyler, andL. H. Sarett, J. Amer. Chem. Soc.75, 422 (1953).CrossRefGoogle Scholar
  9. 2.
    L. Dorfman, Chem. Revs.53, 82 (1953).CrossRefGoogle Scholar
  10. 3.
    A. S. Meyer, manuscript in preparation.Google Scholar
  11. 4.
    A. S. Meyer et al., Acta Endocrin. l. c.Google Scholar
  12. 1.
    A. S. Meyer, manuscript in preparation.Google Scholar
  13. 2a.
    Cf. P. Stiebel andCh. Tamm, Helv. chim. Acta37, 1094 (1954); see also1 for a vinylogous instance.CrossRefGoogle Scholar
  14. 3a.
    G. W. Barber andM. Ehrenstein, J. Org. Chem.19, 1758 (1954).CrossRefGoogle Scholar
  15. 1.
    D. H. R. Barton andP. deMayo, J. Chem. Soc.1954, 887.Google Scholar
  16. 1a.
    We are grateful to Dr.Derek H. R. Barton for having brought to our attention the formaldehyde elimination reaction and for the specimens of the triterpenes employed in this study.Google Scholar
  17. 2.
    W. A. Jacobs, J. Biol. Chem.63, 631 (1925).Google Scholar
  18. 3.
    G. W. Barber andM. Ehrenstein, J. Org. Chem.19, 1758 (1954).CrossRefGoogle Scholar
  19. 4.
    P. Th. Herzig andM. Ehrenstein, J. Org. Chem.17, 713 (1952).CrossRefGoogle Scholar
  20. 7.
    A. L. Wilds andN. A. Nelson, J. Amer. Chem. Soc.75, 5366 (1953).CrossRefGoogle Scholar
  21. 8.
    A. J. Birch, J. Chem. Soc.367 (1950).Google Scholar
  22. 9.
    A. S. Meyer andM. C. Lindberg, Anal. Chem. (in press).Google Scholar
  23. 10.
    A. S. Meyer, manuscript in preparation.Google Scholar
  24. 1.
    These data would thus confirm that 19-hydroxyprogesterone and 19-hydroxydesoxycorticosterone, prepared byEhrenstein and co-workers from strophanthidin, have the normal steroid configuration. (G. W. Barber, M. Ehrenstein, J. Org. Chem.19, 1758 [1954]).CrossRefGoogle Scholar
  25. 2.
    E. Eisenberg andG. S. Gordan, J. Pharmacol. Exper. Therapy99, 38 (1950).Google Scholar
  26. 3.
    R. I. Dorfman, Endocr.42, 1 (1948).Google Scholar
  27. 4.
    M. R. Cook, Jr. andF. Elmadjian, J. Amer. Pharm. Assoc.42, 329 (1953).Google Scholar
  28. 5.
    V. Schenker, Endocr.53, 345 (1953).Google Scholar
  29. 6.
    Cf. reviews byL. F. Fieser andM. Fieser,Natural Products Related to Phenanthrene, 3rd ed. (New York, 1949);H. Heusser, Progr. Chem. Organic Natural Products7, 87 (1950);T. Reichstein, Angew. Chemie63, 412 (1951);A. Stoll, Exper.10, 282 (1954).Google Scholar
  30. 7.
    G. W. Barber andM. Ehrenstein, J. Org. Chem.19, 1758 (1954).CrossRefGoogle Scholar
  31. 8.
    W. W. Tullner andR. Hertz, Endocr.52, 359 (1953).Google Scholar
  32. 8a.
    L. G. Hershberger, E. G. Shipley, andR. K. Meyer, Proc. Exptl. Biol. Med.83, 175 (1953).Google Scholar
  33. 8b.
    A. Sandoval, L. Miramontes, G. Rosenkranz, C. Djerassi, andF. Sondheimer, J. Amer. Chem. Soc.75, 4117 (1953).CrossRefGoogle Scholar
  34. 9.
    Cf., inter al.,M. Ehrenstein,A. R. Johnson,P. C. Olmsted,V. I. Vivian, andM. A. Wagner, J. Org. Chem.15, 264 (1950).CrossRefGoogle Scholar
  35. 9a.
    G. W. Barber andM. Ehrenstein, J. Org. Chem.19, 363 (1954).Google Scholar
  36. 9b.
    E. B. Hershberg, M. Rubin, andE. Schwenk, J. Org. Chem.15, 292 (1950).CrossRefGoogle Scholar
  37. 1.
    D. Beall, J. Endocr.2, 81 (1940).Google Scholar
  38. 2.
    M. Hayano andR. I. Dorfmann, J. Biol. Chem.211, 227 (1954).Google Scholar

Copyright information

© Birkhäuser Verlag 1955

Authors and Affiliations

  • A. S. Meyer
    • 1
  1. 1.Worcester Foundation for Experimental BiologyShrewsbury

Personalised recommendations